Drugs / CocoaVia®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT03123068 Comparator | Apr 2017 → Dec 2018 | — | Stanford University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CocoaVia | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03123068 ↗ |
| Route | Oral | “preemptive oral administration of cocoa flavanol” NCT03123068 ↗ |
| Target | HMGB1 | “decreases plasma levels of HMGB1” NCT03123068 ↗ |